𝔖 Bobbio Scriptorium
✦   LIBER   ✦

2′-Behenoyl-paclitaxel conjugate containing lipid nanoparticles for the treatment of metastatic breast cancer

✍ Scribed by Ma, Ping; Rahima Benhabbour, S.; Feng, Lan; Mumper, Russell J.

Book ID
123342054
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
678 KB
Volume
334
Category
Article
ISSN
0304-3835

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized phase 2 trial comparing 3-h
A randomized phase 2 trial comparing 3-hour versus 96-hour infusion schedules of paclitaxel for the treatment of metastatic breast cancer
✍ Stacy L. Moulder; Frankie A. Holmes; Anthony W. Tolcher; Peter Thall; Kristine B 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB

## Abstract ## BACKGROUND: This study was performed to compare efficacy and toxicity profiles of paclitaxel using 3‐hour versus 96‐hour infusion schedules. ## METHODS: Patients with metastatic breast cancer (MBC) were randomly assigned to receive paclitaxel starting at a dose of 250 mg/m^2^ intr

Vinorelbine and cisplatin (CIVIC regimen
Vinorelbine and cisplatin (CIVIC regimen) for the treatment of metastatic breast carcinoma after failure of anthracycline- and/or paclitaxel-containing regimens
✍ Isabelle Ray-Coquard; Pierre Biron; Thomas Bachelot; Jean-Paul Guastalla; Gilles 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 2 views

## Background: A pilot study of a new chemotherapy, the civic regimen, was performed in 58 patients with metastatic breast carcinoma previously treated with chemotherapy with or without hormonal therapy (n = 41). cisplatin, 20 mg/m2/day, was given (days 1-5) every 21 days during a 1-hour intravenou